We are live on ! Find out more
PBH icon

Prestige Consumer Healthcare

356 hedge funds and large institutions have $3.17B invested in Prestige Consumer Healthcare in 2025 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 126 increasing their positions, 134 reducing their positions, and 59 closing their positions.

New
Increased
Maintained
Reduced
Closed

6% less repeat investments, than reductions

Existing positions increased: 126 | Existing positions reduced: 134

2.05% less ownership

Funds ownership: 105.31%103.26% (-2.1%)

6% less funds holding

Funds holding: 378356 (-22)

24% less capital invested

Capital invested by funds: $4.16B → $3.17B (-$983M)

25% less first-time investments, than exits

New positions opened: 44 | Existing positions closed: 59

100% less funds holding in top 10

Funds holding in top 10: 20 (-2)

Holders
356
Holders Change
-22
Holders Change %
-5.82%
% of All Funds
4.67%
Holding in Top 10
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-100%
% of All Funds
New
44
Increased
126
Reduced
134
Closed
59
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
UBS Group
26
UBS Group
Switzerland
$26.2M +$2.56M +36,770 +10%
Bank of New York Mellon
27
Bank of New York Mellon
New York
$22M -$1.47M -21,056 -6%
ACB
28
Aristotle Capital Boston
Massachusetts
$20.3M -$309K -4,436 -1%
LI
29
Leeward Investments
Massachusetts
$19.6M -$493K -7,085 -2%
BIP
30
Brandes Investment Partners
California
$19.6M +$20.6M +295,908 +1,636%
Squarepoint
31
Squarepoint
New York
$18.8M +$16M +229,311 +316%
Wells Fargo
32
Wells Fargo
California
$18.6M +$3.42M +49,180 +20%
CAM
33
Congress Asset Management
Massachusetts
$18.4M -$49.7M -714,172 -71%
Fisher Asset Management
34
Fisher Asset Management
Washington
$18.3M -$830K -11,917 -4%
Bessemer Group
35
Bessemer Group
New Jersey
$17.3M -$7M -100,620 -27%
Capital Research Global Investors
36
Capital Research Global Investors
California
$16.9M -$1.8M -25,838 -9%
Principal Financial Group
37
Principal Financial Group
Iowa
$16.5M +$72.3K +1,039 +0.4%
N
38
Nuveen
North Carolina
$15.9M +$6.5M +93,397 +58%
Jennison Associates
39
Jennison Associates
New York
$15.7M -$1.09M -15,727 -6%
GIM
40
Glenmede Investment Management
Pennsylvania
$15.7M -$1.05M -15,058 -6%
Envestnet Asset Management
41
Envestnet Asset Management
Illinois
$15.5M -$1.41M -20,285 -8%
Renaissance Technologies
42
Renaissance Technologies
New York
$14.3M -$12.3M -176,602 -44%
Natixis Advisors
43
Natixis Advisors
Massachusetts
$13.5M -$4.97M -71,397 -25%
NSAM
44
North Star Asset Management
Wisconsin
$12M -$137K -1,967 -1%
Public Sector Pension Investment Board (PSP Investments)
45
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$12M +$194K +2,790 +1%
TCM
46
Tributary Capital Management
Nebraska
$11.8M +$2.94M +42,264 +29%
SEI Investments
47
SEI Investments
Pennsylvania
$10M -$1.75M -25,172 -14%
RhumbLine Advisers
48
RhumbLine Advisers
Massachusetts
$9.74M +$52K +747 +0.5%
NC
49
Nicholas Company
Wisconsin
$9.45M -$2.09K -30 -0%
Legal & General Group
50
Legal & General Group
United Kingdom
$8.11M -$556K -7,984 -6%

PBH Hedge Fund Activity: Q3 2025 in Review

356 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Prestige Consumer Healthcare (PBH) for Q3 2025, worth a combined $3.17B — down 24% from $4.16B a quarter earlier.

Sellers outnumbered buyers: 59 funds closed out of PBH and 44 opened new positions — a net loss of 15 holders — while 134 trimmed existing stakes and 126 added.

The largest buyer was Ariel Investments, adding an estimated $96.9M. The largest seller was Invesco, cutting an estimated $50.9M.

  • 356 institutional investors held Prestige Consumer Healthcare (PBH) as of Q3 2025, down from 378 in Q2 2025.
  • Funds reported $3.17B of Prestige Consumer Healthcare stock for Q3 2025, down 24% quarter-over-quarter.
  • 44 funds opened new Prestige Consumer Healthcare positions in Q3 2025 and 59 closed out, a net change of -15 holders.
  • The largest Prestige Consumer Healthcare buyer in Q3 2025 was Ariel Investments, an estimated $96.9M added.
  • The largest Prestige Consumer Healthcare seller in Q3 2025 was Invesco, an estimated $50.9M sold.

Based on aggregated 13F filings for Q3 2025.